Medical News

RSS

Muscle Flex changes name to Bravada International

Muscle Flex Inc. announced today that in it will be changing its name to Bravada International Ltd., a name that more accurately reflects the company's growing depth of its business affairs. Muscle Flex® will remain an integral part of the company as the health and fitness product and services brand.

24 Feb 2010

State regulators criticize Obama plan to create federal authority over health insurance rates

Kaiser Health News staff writers Phil Galewitz and Julie Appleby spoke with three veteran state insurance commissioners and found that "state insurance regulators said President Barack Obama goes too far with his proposal

24 Feb 2010

Smith & Nephew launches DYONICS RF System to remove soft tissue during arthroscopic surgery

Smith & Nephew's Endoscopy Division today announced the launch of the DYONICS™ RF System, which incorporates a compact generator with a family of probes for aggressively removing defects and smoothing soft tissue during arthroscopic surgery.

24 Feb 2010

Life Technologies adds SOLiD PI System to sequencing solutions portfolio

Life Technologies Corporation today announced plans for the Applied Biosystems SOLiD™ PI System, a new highly accurate, flexible and easy-to-use genomic analysis platform that will bring next-generation sequencing within the grasp of all life science research laboratories worldwide. Early customer adoption of the SOLiD PI System is expected to begin in the second half of 2010.

24 Feb 2010

Sound Physicians integrates Mount Carmel East Hospital’s hospitalist services

Sound Physicians, a leading hospital medicine organization, recently integrated Mount Carmel East Hospital’s hospitalist services. Mount Carmel East joins a number of hospitals enlisting Sound Physicians to transition their existing private practice affiliated hospitalist groups into a comprehensive hospitalist program, managed by Sound Physicians.

24 Feb 2010

Shire receives FDA Fast Track designation for REPLAGAL

Shire plc, the global specialty biopharmaceutical company, announces it has received Fast Track designation from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement therapy for Fabry disease.

24 Feb 2010

ViroPharma reports 76% growth in fourth-quarter net product sales

ViroPharma Incorporated reported today its financial results for the fourth quarter and year ended December 31, 2009.

24 Feb 2010

Nutrition 21: Health Canada approves chromium picolinate for sale as a natural health product

Nutrition 21, Inc., the developer and marketer of nutritional ingredients for the dietary supplement, functional food and beverage markets announced today that chromium picolinate has been officially approved for sale in Canada as a natural health product by Health Canada, the Canadian federal agency devoted to maintaining and improving the health of the nation's citizens. As a result of this approval, Nutrition 21 can now sell its Chromax® brand of chromium picolinate to Canadian manufacturers, marketers, and importers of natural health products.

24 Feb 2010

Five Prime Therapeutics receives milestone payment for selection of therapeutic program

Five Prime Therapeutics, Inc. today announced it received a milestone payment from Centocor Research & Development, Inc. for the selection of a therapeutic that will be pursued for immunology-related indications. Under the collaboration, FivePrime identified multiple potential therapeutic targets through screening its comprehensive proprietary protein library in cell-based assays that were focused on therapeutic pathways underlying specific immune and inflammatory disorders.

24 Feb 2010

Genetic test for autism: Transgenomic licenses exclusive intellectual property from IntegraGen

Transgenomic, Inc. announced today that it has licensed on an exclusive U.S. basis intellectual property from IntegraGen SA that will enable Transgenomic to develop and commercialize a genetic test designed to assess the risk of autism in children who have older siblings diagnosed with an autism spectrum disorder. Under the agreement Transgenomic will develop the test in the Company's CAP-accredited and CLIA-certified laboratory, and anticipates launching the new test in the second quarter of 2010. Financial terms of the agreement were not disclosed.

24 Feb 2010

Manduka announces the debut of eQua Hot Yoga Towel

Manduka (www.manduka.com), the world's leader in high performance yoga gear, announced today the debut of the eQua Hot Yoga Towel—the newest addition to the Manduka eQua Towel Collection. For those that prefer their yoga hot, the eQua Hot Yoga Towel is the ultimate solution to sweat management—allowing the user to perfect their poses instead of dealing with a perspiring distraction from their practice.

24 Feb 2010

Incidence rate for all causes of dementia in older people to increase with age: Study

University of California researchers found that the incidence rate for all causes of dementia in people age 90 and older is 18.2% annually and significantly increases with age in both men and women. This research, called "The 90+ Study," is one of only a few to examine dementia in this age group, and the first to have sufficient participation of centenarians.

24 Feb 2010

Almost Family's fourth-quarter net service revenues up 18%

Almost Family, Inc., a leading regional provider of home health nursing services, announced today its financial results for the three months and full year ended December 31, 2009.

24 Feb 2010

TSO3 files final short form prospectus with respect to 10M common share public offering

TSO3 Inc. is pleased to announce that it has filed a final short form prospectus with the securities regulatory authorities in all provinces of Canada with respect to a previously announced public offering of 10,000,000 common shares for gross proceeds to the Company of C$16 million. The prospectus also qualifies for the distribution of 150,000 Common shares sold by Simon Robitaille, one of the Company's founders and Chief Scientific Officer, for gross proceeds of $240,000.

24 Feb 2010

Merge Healthcare executes definitive commitment letter for $200M of bridge financing to acquire AMICAS

Merge Healthcare Incorporated today announced that it and Morgan Stanley Senior Funding, Inc. have executed a definitive commitment letter for $200 million of bridge financing to finance, in part, Merge’s proposed acquisition of AMICAS, Inc..

24 Feb 2010

Observational study on mild demonstrates acute safety of procedure in treatment of LSS

Medical device company Vertos Medical Inc. has reported that an observational study on mild, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).

24 Feb 2010

First convertible endotracheal tube launched by Teleflex Medical

Teleflex Medical has announced the introduction of the Teleflex ISIS™ HVT™, the first convertible endotracheal tube. The Teleflex ISIS HVT features an integrated suction port and separate suction line allowing for subglottic secretion suctioning on demand. Now clinicians can be free from the burden of choosing which tube is best for the patient at the time of intubation. When needed, the suction tube attaches to the Teleflex ISIS HVT via a secure locking connection.

24 Feb 2010

Osiris Therapeutics' net income for fourth-quarter 2009 increases to $15.7M

Osiris Therapeutics, Inc., the leading stem cell therapeutic company focused on developing and marketing products to treat medical conditions in the inflammatory, cardiovascular and orthopedic areas, announced today its results for the fourth quarter and year ended December 31, 2009.

24 Feb 2010

NeHII implements Axolotl’s Elysium Exchange platform at Mary Lanning Memorial Hospital

NeHII, the Nebraska Health Information Initiative, a statewide Health Information Exchange (HIE) designed to share clinical and administrative data among providers in Nebraska, today announced its successful expansion to Central Nebraska. The physicians and medical staff of Mary Lanning Memorial Hospital, serving the city of Hastings, are able to communicate electronically and exchange patient information with other hospitals and physicians throughout the state.

24 Feb 2010

Par Pharmaceutical reports total revenues of $1,193.2 million for 2009

Par Pharmaceutical Companies, Inc. today reported results for the fourth quarter and full year ended December 31, 2009.

24 Feb 2010

Medical News

Muscle Flex changes name to Bravada International

State regulators criticize Obama plan to create federal authority over health insurance rates

Smith & Nephew launches DYONICS RF System to remove soft tissue during arthroscopic surgery

Life Technologies adds SOLiD PI System to sequencing solutions portfolio

Sound Physicians integrates Mount Carmel East Hospital’s hospitalist services

Shire receives FDA Fast Track designation for REPLAGAL

ViroPharma reports 76% growth in fourth-quarter net product sales

Nutrition 21: Health Canada approves chromium picolinate for sale as a natural health product

Five Prime Therapeutics receives milestone payment for selection of therapeutic program

Genetic test for autism: Transgenomic licenses exclusive intellectual property from IntegraGen

Manduka announces the debut of eQua Hot Yoga Towel

Incidence rate for all causes of dementia in older people to increase with age: Study

Almost Family's fourth-quarter net service revenues up 18%

TSO3 files final short form prospectus with respect to 10M common share public offering

Merge Healthcare executes definitive commitment letter for $200M of bridge financing to acquire AMICAS

Observational study on mild demonstrates acute safety of procedure in treatment of LSS

First convertible endotracheal tube launched by Teleflex Medical

Osiris Therapeutics' net income for fourth-quarter 2009 increases to $15.7M

NeHII implements Axolotl’s Elysium Exchange platform at Mary Lanning Memorial Hospital

Par Pharmaceutical reports total revenues of $1,193.2 million for 2009

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News